efficacy of semaglutide and tirzepatide in reducing liver fat A 72-week trial compared the two leading GLP-1 medications adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide vs. Semaglutide for Patients

Dalli-Rajhara, Punganur, Mattannur, Mathura, Thakurdwara, Nandivaram-Guduvancheri, Mulbagal, Manjlegaon, Wankaner, Sillod, Nidadavole, Surapura, Rajagangapur, Sheikhpura, Parlakhemundi, Kalimpong, Siruguppa, Arvi, Limbdi, Barpeta, Manglaur, Repalle

Gallbladder complications GLP-1 receptor agonists are associated with a slightly increased risk of gallbladder disease, including gallstones and cholecystitis

BPC-157 is one of the most extensively studied peptides in preclinical literature, with a research history spanning over three decades

(Your provider or dietitian can personalize this.) Plan for procedures

Recognized for excellence, we have received accolades like the Times Health Excellence Award in 2024